Lack of Disparities in Pharmacogenomics

Based on personal polymorphism and algorithmic interpretation, pharmacogenomics interventions in healthcare are chosen, directing pharmacotherapies in patients. As a part of precision medicine, pharmacogenomics offers a unique chance to set the bar for treating patients as particular individuals with specific needs. Like with any intervention, the benefit-to-risk ratio needs to be considered. Information gaps and people’s lack of knowledge of pharmacogenomics will always be problems, as will their unfamiliarity with the subject. As there are more genes, there are more potential diseases and environmental factors that could mask the impact of genes. As a result, multigene models in vast populations must always be considered for research. There aren’t many studies that look at how pharmacogenomics affects health disparities. Additional research is needed to assess health differences between ethnic groups and nations and within a single country